RESUMO
Fibroepithelial stromal polyps (FESPs) are benign polypoid mesenchymal lesions thought to arise from desmin-positive specialized stromal cells of the female genital tract. Although most cases are easily diagnosed by morphology alone, the morphology of FESPs is variable and in some instances can contain hypercellular stroma with numerous atypical desmin-positive cells, simulating botryoid embryonal rhabdomyosarcoma (ERMS). Recently, we encountered a cellular FESP showing desmin expression as well as nuclear immunoreactivity for the skeletal muscle-associated transcription factor MyoD1. Although these lesions are widely known to express desmin, there are very few studies examining expression of the more specific markers of skeletal muscle differentiation, myogenin and MyoD1. The aim of our study was to examine desmin, MyoD1, and myogenin expression in a series of 25 FESPs. Of the 25 cases, desmin expression was present in 23 (92%), at least focal MyoD1 expression was present in 10 (40%), and all cases were negative for myogenin. Follow-up data were available for all 25 cases, and none recurred or behaved in a malignant fashion. Awareness of this potential immunohistochemical pitfall and careful morphologic evaluation should allow for the confident distinction of MyoD1-positive FESP from botyroid ERMS in almost all instances.
Assuntos
Biomarcadores Tumorais/análise , Proteína MyoD/análise , Neoplasias Fibroepiteliais/química , Pólipos/química , Células Estromais/química , Neoplasias Vaginais/química , Neoplasias Vulvares/química , Adulto , Idoso , Idoso de 80 Anos ou mais , Diagnóstico Diferencial , Feminino , Humanos , Imuno-Histoquímica , Pessoa de Meia-Idade , Neoplasias Fibroepiteliais/patologia , Pólipos/patologia , Valor Preditivo dos Testes , Prognóstico , Células Estromais/patologia , Neoplasias Vaginais/patologia , Neoplasias Vulvares/patologiaAssuntos
Adenocarcinoma/diagnóstico por imagem , Fluordesoxiglucose F18 , Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada , Compostos Radiofarmacêuticos , Neoplasias Retais/diagnóstico por imagem , Neoplasias Vaginais/diagnóstico por imagem , Adenocarcinoma/química , Adenocarcinoma/secundário , Feminino , Humanos , Metástase Linfática/diagnóstico por imagem , Pessoa de Meia-Idade , Neoplasias Retais/química , Neoplasias Retais/patologia , Neoplasias Vaginais/química , Neoplasias Vaginais/secundárioRESUMO
Intestinal-type adenocarcinoma is a rare primary vaginal carcinoma and considerably more uncommon than metastatic lesions which represent the most frequent malignancy at this anatomic site. Among all malignant tumors, colorectal, breast and female genital tract carcinomas have the tendency to metastasize to the vagina.As morphologic and immunohistochemical features of intestinal-type adenocarcinoma occurring primarily in the vagina are not specific, clinical and radiologic information is crucial to exclude a metastatic lesion.Herein we present a rare case of intestinal-type adenocarcinoma from a villous adenoma, presenting as a polypoid mass in the posterior wall of vaginal introitus of 51-year-old menopausal woman. To the best of our knowledge, only 19 cases of intestinal-type adenocarcinoma of the vagina have been reported in the English literature so far. Notably the origin from a previous villous adenoma has been well documented only in a few cases.
Assuntos
Adenocarcinoma/patologia , Adenoma Viloso/patologia , Neoplasias Vaginais/patologia , Adenocarcinoma/química , Adenocarcinoma/cirurgia , Adenoma Viloso/química , Adenoma Viloso/cirurgia , Biomarcadores Tumorais/análise , Biópsia , Diagnóstico Diferencial , Feminino , Humanos , Imuno-Histoquímica , Pessoa de Meia-Idade , Valor Preditivo dos Testes , Neoplasias Vaginais/química , Neoplasias Vaginais/cirurgiaRESUMO
Mesonephric carcinomas of the gynecologic tract are neoplasms that are often under-recognized due to their varied morphologic appearances. Recently, GATA3 and TTF1 have been reported to be useful immunohistochemical markers for distinguishing mesonephric carcinomas from its morphologic mimics. Herein, we compared the performance of GATA3 and TTF1 to the traditional markers used for mesonephric carcinomas, CD10 and calretinin. We studied 694 cases: 8 mesonephric carcinomas (7 cervical [includes 3 mesonephric carcinosarcomas], 1 vaginal), 5 mesonephric-like carcinomas (4 uterine corpus, 1 ovarian), 585 endometrial adenocarcinomas, and 96 cervical adenocarcinomas. Mesonephric-like carcinomas were defined as tumors exhibiting the classic morphologic features of mesonephric carcinoma, but occurring outside of the cervix and without convincing mesonephric remnants. GATA3 had the highest sensitivity and specificity (91% and 94%) compared with TTF1 (45% and 99%), CD10 (73% and 83%), and calretinin (36% and 89%). GATA3, however, also stained a substantial number of uterine carcinosarcomas (23/113, 20%). TTF1 was positive in 5/5 (100%) mesonephric-like carcinomas and only 1/8 (13%) mesonephric carcinomas. In 4/6 (67%) TTF1 positive cases, GATA3 exhibited an inverse staining pattern with TTF1. In summary, GATA3 was the best overall marker for mesonephric and mesonephric-like carcinomas, but cannot be used to distinguish mesonephric carcinosarcomas from Müllerian carcinosarcomas. The inverse staining pattern between GATA3 and TTF1, suggests that TTF1 may be useful when GATA3 is negative in small biopsies where mesonephric or mesonephric-like carcinoma is suspected. The greater TTF1 positivity in mesonephric-like carcinomas suggests they may be biologically different from prototypical mesonephric carcinomas.
Assuntos
Adenocarcinoma/química , Biomarcadores Tumorais/análise , Calbindina 2/análise , Carcinossarcoma/química , Neoplasias do Endométrio/química , Fator de Transcrição GATA3/análise , Ductos Paramesonéfricos/química , Neprilisina/análise , Fator Nuclear 1 de Tireoide/análise , Neoplasias do Colo do Útero/química , Neoplasias Vaginais/química , Ductos Mesonéfricos/química , Adenocarcinoma/patologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Biópsia , Carcinossarcoma/patologia , Diagnóstico Diferencial , Neoplasias do Endométrio/patologia , Feminino , Humanos , Imuno-Histoquímica , Pessoa de Meia-Idade , Ductos Paramesonéfricos/metabolismo , Valor Preditivo dos Testes , Análise Serial de Tecidos , Neoplasias do Colo do Útero/patologia , Neoplasias Vaginais/patologia , Ductos Mesonéfricos/patologiaRESUMO
So-called gastric-type adenocarcinoma and related premalignant lesions have been characterized in the cervix, but similar lesions are not widely recognized in the vagina. We report a series of 11 vaginal glandular lesions exhibiting gastric differentiation, comprising 5 cases of adenocarcinoma and 6 of adenosis. All cases occurred in adults (aged 33 to 69) with no known history of diethylstilboestrol exposure. The vaginal adenocarcinomas exhibited morphologic features identical to gastric-type adenocarcinoma of the cervix, but 1 case additionally demonstrated basaloid and sarcomatoid components, which have not been previously reported in cervical gastric-type adenocarcinoma. Immunohistochemically, the adenocarcinomas were positive for MUC6 (4/5), PAX8 (3/5), CK7 (5/5), CK20 (1/5), CDX2 (5/5), CA19.9 (5/5), CEA (4/5), CA125 (5/5), and hepatocyte nuclear factor 1ß (5/5). p16, estrogen receptor, and Napsin A were negative in all cases tested, whereas p53 exhibited mutation-type staining in 3/5 cases. In all 5 adenocarcinomas, a component of adenosis with benign or atypical nuclear features was identified; the adenosis displayed gastric morphology in 4 cases and tuboendometrial morphology in 1. The 6 cases of pure vaginal adenosis (without associated adenocarcinoma) all contained gastric-type mucinous glands together with tuboendometrial glands in 2 cases. There was focal intestinal differentiation with goblet cells in all 6 cases and neuroendocrine cells with eosinophilic granules in 3. Cytologic atypia was observed in 4/6 cases of pure vaginal adenosis. Immunohistochemically, the gastric-type adenosis (10 cases) was positive for MUC6 (10/10), estrogen receptor (5/10), PAX8 (8/10), CK7 (9/9), CK20 (2/9), CDX2 (5/9), CA19.9 (8/9), CEA (6/9), CA125 (6/9), hepatocyte nuclear factor 1ß (10/10), and Napsin A (1/10). p53 exhibited wild-type immunoreactivity in all 10 cases, whereas p16 was negative in all cases tested. Scattered individual chromogranin-positive cells were present in all 5 cases of pure adenosis tested. Follow-up was available in 4 of the adenocarcinoma cases, with 3 patients dead of disease within 1 to 3 years and 1 patient alive with disease at 1 year. The morphologic and immunohistochemical findings in our study suggest a close relationship between vaginal gastric-type adenocarcinoma and adenosis exhibiting gastric differentiation. This probably represents a distinct pathway of vaginal gastric-type carcinogenesis analogous to that occurring in the cervix. We propose that gastric-type adenocarcinoma be recognized as a distinct histologic subtype of vaginal adenocarcinoma while vaginal adenosis of gastric-type represents a novel subtype of adenosis that requires further study to clarify its biological potential.
Assuntos
Adenocarcinoma/química , Biomarcadores Tumorais/análise , Diferenciação Celular , Imuno-Histoquímica , Lesões Pré-Cancerosas/metabolismo , Vagina/química , Doenças Vaginais/metabolismo , Neoplasias Vaginais/química , Adenocarcinoma/patologia , Adulto , Idoso , Biópsia , Diagnóstico Diferencial , Feminino , Humanos , Pessoa de Meia-Idade , Lesões Pré-Cancerosas/patologia , Valor Preditivo dos Testes , Vagina/patologia , Doenças Vaginais/patologia , Neoplasias Vaginais/patologiaRESUMO
We report 2 cases of vaginal glomangiomyoma in a 53-year-old who presented with a painful vaginal mass, and a 56-year-old who had postmenopausal bleeding and in whom an incidental vaginal mass was identified and resected at the time of hysterectomy. Histologic examination of the resected masses showed solid, circumscribed, benign, smooth muscle-predominant tumors with interspersed small islands of epithelioid glomus cells. The glomus cells were intimately related to small-caliber blood vessels and showed no cytologic atypia or mitotic activity. The tumor cells showed diffuse expression of smooth muscle actin, CD34, and focal expression of h-caldesmon, vimentin, and estrogen receptor. No immunolabeling for calponin B or desmin was found. To our knowledge, there are only isolated reports of vaginal glomus tumors, and these are the first reported case of vaginal glomangiomyoma in the literature.
Assuntos
Tumor Glômico/patologia , Neoplasias Vaginais/patologia , Actinas/análise , Antígenos CD34/análise , Proteínas de Ligação a Calmodulina/análise , Receptor alfa de Estrogênio/análise , Feminino , Tumor Glômico/química , Tumor Glômico/cirurgia , Humanos , Imuno-Histoquímica , Pessoa de Meia-Idade , Músculo Liso/química , Vagina/patologia , Neoplasias Vaginais/química , Neoplasias Vaginais/cirurgia , VimentinaRESUMO
We report a series of 7 unusual and morphologically distinct cervical or upper vaginal lesions in women aged 41 to 70 years. The lesions involved the cervix in 3 cases, the upper vagina in 2, the cervix and vagina in 1, and in 1 case the site of origin could not be determined. The lesions had a consistent morphologic appearance with a surface "plaque-like" or "stuck-on" configuration apparent in those cases where surrounding normal tissues were present. Broad coalescing solid sheets and interconnecting trabeculae of cytologically bland cells with a rather "basaloid" appearance emanated from the surface and there were scattered squamous eddies. Other features included peripheral palisading and a stroma containing hyalinized basement membrane-like material. Immunohistochemically, the lesions were diffusely positive with p63, CK5/6, and 34ßE12 and focally positive with CK7, but largely negative with CK20, EMA, CEA, and BerEP4. p16 was negative or exhibited nonblock-type immunoreactivity and GATA3 was negative or weakly positive. Molecular testing detected human papillomavirus type 42 in 3 of 7 cases, with no virus detected in the remaining 4 cases. Rarely, similar cases have been reported previously as inverted transitional papilloma of the cervix or vagina, but based on the morphology and immunophenotype we do not feel these represent transitional lesions. We suggest the term seborrheic keratosis-like lesions to designate this new and rare entity, which may be associated with low-risk human papillomavirus infection. Limited follow-up in a small number of cases suggests that these lesions follow a benign clinical course.
Assuntos
Colo do Útero/patologia , Ceratose Seborreica/patologia , Infecções por Parvoviridae/patologia , Neoplasias do Colo do Útero/patologia , Vagina/patologia , Neoplasias Vaginais/patologia , Adulto , Idoso , Biomarcadores Tumorais/análise , Biópsia , Transformação Celular Viral , Colo do Útero/química , Colo do Útero/cirurgia , Colo do Útero/virologia , DNA Viral/genética , Feminino , Testes de DNA para Papilomavírus Humano , Humanos , Imuno-Histoquímica , Ceratose Seborreica/cirurgia , Ceratose Seborreica/virologia , Pessoa de Meia-Idade , Papillomaviridae/genética , Infecções por Parvoviridae/complicações , Infecções por Parvoviridae/virologia , Valor Preditivo dos Testes , Medição de Risco , Fatores de Risco , Neoplasias do Colo do Útero/química , Neoplasias do Colo do Útero/cirurgia , Neoplasias do Colo do Útero/virologia , Vagina/química , Vagina/cirurgia , Vagina/virologia , Neoplasias Vaginais/química , Neoplasias Vaginais/cirurgia , Neoplasias Vaginais/virologiaRESUMO
Adenocarcinomas exhibiting gastric differentiation represent a recently described and uncommon subtype of non-human papillomavirus (HPV)-related cervical adenocarcinoma. They comprise a spectrum from a well-differentiated variant (adenoma malignum/mucinous variant of minimal deviation adenocarcinoma) to a more poorly differentiated overtly malignant form, generally referred to as gastric-type adenocarcinoma. Rarely, such tumors have also been described as primary vaginal neoplasms. Gastric-type adenocarcinomas exhibit considerable morphologic overlap with adenocarcinomas originating outside the female genital tract, especially mucinous adenocarcinomas arising in the pancreas and biliary tract. Moreover, they often metastasize to unusual sites, such as the ovary and peritoneum/omentum, where they can be mistaken for metastatic adenocarcinomas from other, nongynecologic sites. There is little information regarding the immunophenotype of gastric-type adenocarcinomas, and knowledge of this is important to aid in the distinction from other adenocarcinomas. In this study, we undertook a detailed immunohistochemical analysis of a large series of cervical (n=45) and vaginal (n=2) gastric-type adenocarcinomas. Markers included were cytokeratin (CK)7, CK20, CDX2, carcinoembryonic antigen, CA125, CA19.9, p16, estrogen receptor, progesterone receptor, MUC6, PAX8, PAX2, p53, hepatocyte nuclear factor 1 beta, carbonic anhydrase IX, human epidermal receptor 2 (HER2), and mismatch repair (MMR) proteins. All markers were classified as negative, focal (<50% of tumor cells positive), or diffuse (≥50% tumor cells positive) except for p53 (classified as "wild-type" or "mutation-type"), HER2 (scored using the College of American Pathologists guidelines for gastric carcinomas), and MMR proteins (categorized as retained or lost). There was positive staining with CK7 (47/47-45 diffuse, 2 focal), MUC6 (17/21-6 diffuse, 11 focal), carcinoembryonic antigen (25/31-12 diffuse, 13 focal), carbonic anhydrase IX (20/24-8 diffuse, 12 focal), PAX8 (32/47-20 diffuse, 12 focal), CA125 (36/45-5 diffuse, 31 focal), CA19.9 (11/11-8 diffuse, 3 focal), hepatocyte nuclear factor 1 beta (13/14-12 diffuse, 1 focal), CDX2 (24/47-4 diffuse, 20 focal), CK20 (23/47-6 diffuse, 17 focal), and p16 (18/47-4 diffuse, 14 focal). Most cases were negative with estrogen receptor (29/31), progesterone receptor (10/11), PAX2 (18/19), and HER2 (25/26). p53 showed "wild-type" and "mutation-type" staining in 27 of 46 and 19 of 46 cases, respectively. MMR protein expression was retained in 19 of 20 cases with loss of MSH6 staining in 1 patient with Lynch syndrome. Molecular studies for HPV were undertaken in 2 tumors, which exhibited diffuse "block-type" immunoreactivity with p16, and both were negative. This is the first detailed immunohistochemical study of a large series of gastric-type adenocarcinomas of the lower female genital tract. Our results indicate immunophenotypic overlap with pancreaticobiliary adenocarcinomas but suggest that PAX8 immunoreactivity may be especially useful in distinguishing gastric-type adenocarcinomas from pancreaticobiliary and other nongynecologic adenocarcinomas, which are usually negative. Diffuse "block-type" p16 immunoreactivity in a cervical adenocarcinoma is not necessarily indicative of a high-risk HPV-associated tumor.
Assuntos
Adenocarcinoma/química , Biomarcadores Tumorais/análise , Imuno-Histoquímica , Neoplasias do Colo do Útero/química , Neoplasias Vaginais/química , Adenocarcinoma/genética , Adenocarcinoma/patologia , Adenocarcinoma/virologia , Biomarcadores Tumorais/genética , Inibidor p16 de Quinase Dependente de Ciclina/análise , DNA Viral/genética , Feminino , Testes de DNA para Papilomavírus Humano , Humanos , New York , Irlanda do Norte , Fator de Transcrição PAX8 , Fatores de Transcrição Box Pareados/análise , Papillomaviridae/genética , Fenótipo , Valor Preditivo dos Testes , Neoplasias do Colo do Útero/genética , Neoplasias do Colo do Útero/patologia , Neoplasias do Colo do Útero/virologia , Neoplasias Vaginais/genética , Neoplasias Vaginais/patologia , Neoplasias Vaginais/virologiaRESUMO
In 2012, the College of American Pathologists and American Society for Colposcopy and Cervical Pathology published the "LAST" recommendations for histopathology reporting of human papilloma virus-related squamous lesions of the lower anogenital tract, including the use of a 2-tier nomenclature (low-grade squamous intraepithelial lesion/high-grade squamous intraepithelial lesion [LSIL/HSIL]) and expanded use of the biomarker p16 to classify equivocal lesions as either precancer (HSIL) or low-grade lesions (LSIL)/non-human papilloma virus changes. We aimed to determine (1) the frequency with which the poorly reproducible diagnosis of intermediate-grade (-IN 2) lesion in the lower anogenital tract would be downgraded on the basis of p16 results, and (2) whether p16 status was predictive of subsequent higher-grade lesions. A total of 200 specimens diagnosed as an intermediate-grade (-IN 2) lesion of the cervix (168), vagina (2), vulva (2), and anus (28) were reviewed and immunostained for p16. Slides were independently reviewed by 2 pathologists, with discrepant p16 interpretations adjudicated by a third pathologist. Of the 200 cases, 32% were negative for p16. Among the 166 patients with subsequent pathology (including 131 excisions), 26.2% of p16-positive cases versus 4.4% of p16-negative cases were associated with a subsequent diagnosis of HSIL (-IN 3) or worse (P=0.002). Reproducibility of the biopsy diagnosis was fair, with no significant difference with the addition of p16 or using 2 versus 3 tiers. In 11.5% of cases, there was discordance in p16 interpretation (κ 0.735, good agreement). The results indicate that using the Lower Anogenital Squamous Terminology recommendations would result in approximately one third of equivocal (-IN 2) diagnoses being downgraded to LSIL over 1 year in a busy academic practice. The significant association of p16 expression with a higher risk for HSIL on a subsequent specimen suggests that use of p16 to adjudicate equivocal (-IN 2) diagnoses in lower anogenital tract specimens as either LSIL or HSIL would likely predict lesion grade more accurately and avoid unnecessary excisional procedures.
Assuntos
Neoplasias do Ânus/química , Biomarcadores Tumorais/análise , Inibidor p16 de Quinase Dependente de Ciclina/análise , Lesões Intraepiteliais Escamosas Cervicais/metabolismo , Displasia do Colo do Útero/química , Neoplasias do Colo do Útero/química , Neoplasias Vaginais/química , Neoplasias Vulvares/química , Adulto , Idoso , Neoplasias do Ânus/patologia , Neoplasias do Ânus/terapia , Neoplasias do Ânus/virologia , Biópsia , Feminino , Humanos , Imuno-Histoquímica , Masculino , Pessoa de Meia-Idade , Gradação de Tumores , Variações Dependentes do Observador , Infecções por Papillomavirus/virologia , Valor Preditivo dos Testes , Reprodutibilidade dos Testes , Lesões Intraepiteliais Escamosas Cervicais/patologia , Lesões Intraepiteliais Escamosas Cervicais/terapia , Lesões Intraepiteliais Escamosas Cervicais/virologia , Neoplasias do Colo do Útero/patologia , Neoplasias do Colo do Útero/terapia , Neoplasias do Colo do Útero/virologia , Neoplasias Vaginais/patologia , Neoplasias Vaginais/terapia , Neoplasias Vaginais/virologia , Neoplasias Vulvares/patologia , Neoplasias Vulvares/terapia , Neoplasias Vulvares/virologia , Adulto Jovem , Displasia do Colo do Útero/patologia , Displasia do Colo do Útero/terapia , Displasia do Colo do Útero/virologiaRESUMO
Vaginal metastasis from pancreatic cancer is an extreme case and often indicates a poor prognosis. We present a case of pancreatic carcinoma with metastasis to the vagina that was discovered by vaginal bleeding. To our knowledge, this is the third case in the world of a primary pancreatic adenocarcinoma discovered of symptoms from a vaginal metastasis.
Assuntos
Adenocarcinoma Mucinoso/secundário , Neoplasias Pancreáticas/patologia , Neoplasias Vaginais/secundário , Adenocarcinoma Mucinoso/química , Adenocarcinoma Mucinoso/complicações , Adenocarcinoma Mucinoso/patologia , Idoso , Biomarcadores Tumorais/análise , Biópsia , Feminino , Hemorragia/etiologia , Humanos , Queratina-19/análise , Queratina-20/análise , Neoplasias Pancreáticas/diagnóstico por imagem , Tomografia Computadorizada por Raios X , Vagina , Neoplasias Vaginais/química , Neoplasias Vaginais/complicações , Neoplasias Vaginais/patologiaRESUMO
Perivascular epithelioid cell tumors (PEComas) are a family of rare mesenchymal neoplasms, including angiomyolipoma, clear-cell "sugar" tumor of the lung and extrapulmonary sites, lymphangioleiomyomatosis, clear-cell myomelanocytic tumor of the falciform ligament/ligamentum teres, and clear-cell tumors at various other anatomic sites. These tumors are characterized by a proliferation of epithelioid cells with clear to eosinophilic cytoplasm, perivascular distribution, and coexpression of myogenic and melanocytic markers. PEComas show a female predominance, occur with some frequency in the gynecological tract, and have an unpredictable biological behavior. We report a case of a huge malignant PEComa arising from the uterine cervix and vagina. To the best of our knowledge, only 6 cases of PEComa in the cervix and 2 cases in the vagina have been reported in the literature.
Assuntos
Neoplasias de Células Epitelioides Perivasculares/patologia , Neoplasias do Colo do Útero/patologia , Neoplasias Vaginais/patologia , Biomarcadores Tumorais/análise , Feminino , Humanos , Imuno-Histoquímica , Pessoa de Meia-Idade , Imagem Multimodal/métodos , Neoplasias de Células Epitelioides Perivasculares/química , Neoplasias de Células Epitelioides Perivasculares/cirurgia , Tomografia por Emissão de Pósitrons , Tomografia Computadorizada por Raios X , Carga Tumoral , Neoplasias do Colo do Útero/química , Neoplasias do Colo do Útero/cirurgia , Neoplasias Vaginais/química , Neoplasias Vaginais/cirurgiaRESUMO
OBJECTIVE: To investigate the clinicopathologic characteristics, differential diagnosis and biological behavior of extracardiac rhabdomyoma. METHODS: Nine cases of extracardiac rhabdomyoma diagnosed between January of 1997 and July of 2014 were reviewed. The clinical, pathologic and immunohistochemical profiles were evaluated. RESULTS: There were 5 males and 4 females at diagnosis with age ranging from 2 years and three months to 59 years (mean, 37.6 years). Sites included the head and neck region (7 cases), chest (1 case ) and vagina wall (1 case). Clinically, most cases manifested as a subcutaneous nodule or as a submucosal polypoid lesion with a mean diameter of 3.2 cm. Histologically, 4 were adult-type rhabdomyoma characterized by tightly packed large round or polygonal rhabdomyoblasts with abundant eosinophilic to clear cytoplasm; 3 were myxoid variant of fetal rhabdomyoma composed of immature myofibrils, spindled and primitive mesenchymal cells embedded in a myxoid background, 1 was an intermediate form of fetal rhabdomyoma consisting of densely arranged differentiated myoblasts with little myxoid stroma; 1 was a genital rhabdomyoma composed of elongated or strap-like myoblasts scattered in loose fibrous connective tissue. By immunohistochemistry, they showed diffuse and strong positivity for desmin, MSA and myoglobin with variable expression of myogenin. A case of intermediate type also stained for α-smooth muscle actin. Follow up data (2 months ~ 17 years) showed local recurrence in one patient 6 months after surgery. CONCLUSIONS: Rhabdomyoma is a distinctively rare benign mesenchymal tumor showing skeletal muscle differentiation, which may occassionally recur if incompletely excised. Familiarity with its clinical and morphological variants is essential to avoid misdiagnosing this benign lesion as embryonal rhabdomyosarcoma.
Assuntos
Neoplasias de Cabeça e Pescoço/patologia , Rabdomioma/patologia , Neoplasias Torácicas/patologia , Parede Torácica/patologia , Neoplasias Vaginais/patologia , Adolescente , Adulto , Diferenciação Celular , Criança , Pré-Escolar , Desmina/análise , Diagnóstico Diferencial , Feminino , Neoplasias de Cabeça e Pescoço/química , Humanos , Imuno-Histoquímica , Masculino , Mesenquimoma/patologia , Pessoa de Meia-Idade , Miogenina/análise , Recidiva Local de Neoplasia , Rabdomioma/química , Rabdomiossarcoma Embrionário/patologia , Neoplasias Torácicas/química , Neoplasias Vaginais/químicaRESUMO
Endometrial stromal sarcoma (ESS) arising in the vagina is an extremely rare extrauterine endometrial stroma sarcoma, with only 4 cases reported in the literature up to date. Here we report a case of neoplasm originating from vagina. A 32-year-old woman complained of intermittent vaginal bleeding especially after intercourse. A mass with a diameter of 1.0 cm was found in the middle and upper segments of the right posterior vaginal wall. Biopsy showed ESS. Total abdominal hysterectomy, unilateral salpingo-oophorectomy (right) and partial vaginectomy were performed. No ESS lesion was found in endometrium. The patient received six courses of platinum-containing combination chemotherapy after surgery and was free of tumor 18 months after the diagnosis of ESS. The diagnosis of ESS relies on pathologic examination. CD10 is the most useful immunohistochemical marker for the diagnosis of this tumor. The mainstay treatment of ESS is surgery. Local excision and ovarian retaining may be considered in premenopausal women.
Assuntos
Neoplasias do Endométrio/patologia , Sarcoma do Estroma Endometrial/patologia , Neoplasias Vaginais/patologia , Adulto , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Biomarcadores Tumorais/análise , Biópsia , Quimioterapia Adjuvante , Neoplasias do Endométrio/química , Neoplasias do Endométrio/cirurgia , Feminino , Procedimentos Cirúrgicos em Ginecologia , Humanos , Imuno-Histoquímica , Sarcoma do Estroma Endometrial/química , Sarcoma do Estroma Endometrial/cirurgia , Fatores de Tempo , Resultado do Tratamento , Carga Tumoral , Neoplasias Vaginais/química , Neoplasias Vaginais/cirurgiaAssuntos
Adenocarcinoma/diagnóstico , Adenocarcinoma/cirurgia , Exenteração Pélvica , Fístula Retovaginal/complicações , Neoplasias Vaginais/diagnóstico , Neoplasias Vaginais/cirurgia , Adenocarcinoma/sangue , Adenocarcinoma/química , Adenocarcinoma/etiologia , Adenocarcinoma/patologia , Anus Imperfurado/cirurgia , Biomarcadores Tumorais/análise , Biomarcadores Tumorais/sangue , Colostomia , Feminino , Humanos , Imuno-Histoquímica , Recém-Nascido , Neoplasias Pulmonares/secundário , Pessoa de Meia-Idade , Estadiamento de Neoplasias , Fístula Retovaginal/etiologia , Derivação Urinária , Neoplasias Vaginais/sangue , Neoplasias Vaginais/química , Neoplasias Vaginais/etiologia , Neoplasias Vaginais/patologiaRESUMO
The case of a female patient of 35 years of age, with a pedunculated tumor dependent of the vagina, of approximately 25 x 12 x 8 cm, who had a wide resection. The report was consistent with myxoid aggressive angiomyxoma. This is a myxoid mesenchymal neoplasm of slow growth, which mainly appears in deep soft tissues of the pelvic, genital or perineal areas of adult women. It is usually diagnosed after surgical resection by histopathologic examination. Routine evaluation includes: complete physical examination, imaging and pathology report of diagnostic confirmation.
Assuntos
Mixoma/patologia , Neoplasias Hormônio-Dependentes/patologia , Neoplasias Vaginais/patologia , Adulto , Antineoplásicos Hormonais/uso terapêutico , Biomarcadores Tumorais , Terapia Combinada , Diagnóstico por Imagem , Feminino , Hormônio Liberador de Gonadotropina/agonistas , Gosserrelina/uso terapêutico , Humanos , Mixoma/química , Mixoma/diagnóstico , Mixoma/tratamento farmacológico , Mixoma/cirurgia , Invasividade Neoplásica , Proteínas de Neoplasias/análise , Neoplasias Hormônio-Dependentes/química , Neoplasias Hormônio-Dependentes/diagnóstico , Neoplasias Hormônio-Dependentes/tratamento farmacológico , Neoplasias Hormônio-Dependentes/cirurgia , Progesterona , Receptores de Progesterona/análise , Carga Tumoral , Neoplasias Vaginais/química , Neoplasias Vaginais/diagnóstico , Neoplasias Vaginais/tratamento farmacológico , Neoplasias Vaginais/cirurgiaAssuntos
Carcinoma/diagnóstico , Neoplasias Embrionárias de Células Germinativas/diagnóstico , Neoplasias Vaginais/diagnóstico , Actinas/análise , Antígenos CD34/análise , Biomarcadores Tumorais , Carcinoma/química , Carcinoma/classificação , Carcinoma/patologia , Diagnóstico Diferencial , Feminino , Humanos , Queratinas/análise , Mesoderma/patologia , Mixoma/diagnóstico , Neoplasias Embrionárias de Células Germinativas/química , Neoplasias Embrionárias de Células Germinativas/patologia , Neprilisina/análise , Proteínas Proto-Oncogênicas c-bcl-2/análise , Neoplasias Vaginais/química , Neoplasias Vaginais/patologia , Adulto JovemRESUMO
Spread of urothelial carcinoma (UC) to the female genital tract occurs in a small subset of women with UC. We studied 6 patients with involvement of various gynecologic (GYN) sites and detailed natural history and pathologic features. Four patients initially presented with bladder lesions, including 1 high-grade pTa tumor, 2 pT1 tumors, and 1 pT2 tumor; 1 patient presented with pT2 disease of the renal pelvis and 1 with GYN involvement in the form of vulvar Paget's disease. For the 5 patients presenting with UC, time to GYN involvement was 2 to 8 years; vaginal bleeding (n=4) was the main presenting symptom, and the first site of involvement was the vagina (n=4) or cervix (n=1). GYN sites displayed an array of morphologies and growth patterns that may be seen in both UC and GYN primary tumors. The presence or absence of invasion in the original UC did not dictate whether GYN sites would exhibit invasive disease or whether disease would present as continuous or "skip" lesions. Immunohistochemistry for at least 1 GYN site per patient revealed diffuse, strong CK7 and focal to diffuse strong CK20 positivity in all cases, as well as at least focal p16 positivity in 5 of 6 cases. HPV in situ hybridization was negative in all cases. At last follow-up, 3 patients had died from UC and 3 were alive with recurrent disease/documented metastasis. Our findings highlight the morphologic and immunohistochemical overlap between primary GYN squamous lesions and GYN involvement by UC and hence the importance of clinical history in ensuring an accurate diagnosis.
Assuntos
Biomarcadores Tumorais/análise , Carcinoma/secundário , Imuno-Histoquímica , Neoplasias da Bexiga Urinária/patologia , Urotélio/patologia , Neoplasias do Colo do Útero/secundário , Neoplasias Vaginais/secundário , Idoso , Idoso de 80 Anos ou mais , Carcinoma/química , Carcinoma/complicações , Carcinoma/virologia , DNA Viral/isolamento & purificação , Progressão da Doença , Feminino , Humanos , Pessoa de Meia-Idade , Gradação de Tumores , Invasividade Neoplásica , Cidade de Nova Iorque , Papillomaviridae/genética , Valor Preditivo dos Testes , Estudos Retrospectivos , Fatores de Tempo , Neoplasias da Bexiga Urinária/química , Urotélio/química , Neoplasias do Colo do Útero/química , Neoplasias do Colo do Útero/complicações , Neoplasias do Colo do Útero/virologia , Hemorragia Uterina/etiologia , Neoplasias Vaginais/química , Neoplasias Vaginais/complicações , Neoplasias Vaginais/virologiaRESUMO
Aggressive angiomyxoma (AA) is a rare mesenchimal tumor usually located in the pelvic and perineal region. Less than 30 cases of aggressive angiomyxoma with vaginal location have been reported in the literature up to this date. The authors report the case of a 50-year-old female patient diagnosed with vaginal AA whose characteristics at its initial stage were macroscopically indistinguishable from those of a polypoid lesion. Therefore this case suggests that this type of tumor should be considered as part of the differential diagnosis of vaginal polypoid lesions.
Assuntos
Mixoma/patologia , Neoplasias Vaginais/patologia , Feminino , Proteína HMGA2/análise , Humanos , Pessoa de Meia-Idade , Mixoma/química , Mixoma/terapia , Estadiamento de Neoplasias , Neoplasias Vaginais/química , Neoplasias Vaginais/terapiaRESUMO
Primary transitional cell carcinoma (TCC) of the vagina represents an extremely rare neoplasm and is associated with multicentric TCC of the urinary tract in all described cases. A case of multicentric TCC of the vagina and the left ureter in a 73-year-old woman is reported. Immunohistochemical analysis of cytokeratin expression was performed. Immunohistochemistry proved to play an important role in the differential diagnosis of vaginal TCC, supported the morphological diagnosis of TCC, and largely excluded the diagnosis of vaginal papillary carcinoma with transitional features as a morphological variant of squamous cell carcinoma. Subsequent urological examination revealed multicentric TCC of the left ureter. During the follow up, the metastases of the vaginal TCC into the regional inguinal lymph nodes were diagnosed, suggesting that indolent clinical course is not a rule in this type of tumor.
Assuntos
Carcinoma de Células de Transição/secundário , Neoplasias Ureterais/patologia , Neoplasias Vaginais/patologia , Idoso , Carcinoma de Células de Transição/química , Carcinoma de Células de Transição/terapia , Terapia Combinada , Evolução Fatal , Feminino , Humanos , Linfonodos/patologia , Metástase Linfática , Neoplasias Primárias Múltiplas , Cuidados Paliativos , Neoplasias Ureterais/química , Neoplasias Vaginais/química , Neoplasias Vaginais/terapiaRESUMO
The patient was a 57-year-old white woman who presented with a 3.0 x 2.0-cm partially ulcerated vaginal polyp. Histology revealed a malignant mixed mullerian tumor composed of invasive squamous cell carcinoma with deeper areas of undifferentiated pleomorphic sarcoma. Invasive carcinoma had overlying high-grade vaginal intraepithelial neoplasia (VaIN III), which contained koilocytic atypia. In situ hybridization detected high-risk human papillomavirus DNA in both the carcinoma and the sarcoma components.